Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab
Clinical trial NCT03871829 · TERMINATED
Trial details
- NCT number
- NCT03871829
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-31
- Primary completion
- 2022-10-24
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.